Sanofi India Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on May 15, 2025
SANOFI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sanofi India held its 69th AGM on May 15, 2025 via video conferencing, attended by 76 shareholders. The meeting ran from 3:30 PM to 4:55 PM. Eight resolutions were tabled, including adoption of audited financial statements for FY ended December 31, 2024, and declaration of a final dividend of Rs. 117 per equity share (face value Rs. 10). Directors Ms. Renee Amonkar and Mr. Rachid Ayari were re-appointed by rotation, Mr. Rahul Bhatnagar was re-appointed as Independent Director for a second 5-year term, and Mr. Rodolfo Hrosz was re-designated as Non-Executive Director after his tenure as Managing Director. M/s. Parikh & Associates was appointed as Secretarial Auditor for FY 2025–2029, and cost auditor remuneration for FY 2025 was ratified. The Chairman and CFO addressed shareholder queries, and e-voting results will be announced within the statutory timeline.
The Rs. 117 final dividend is the key shareholder takeaway, representing a substantial payout on the Rs. 10 face value. The AGM proceedings are largely procedural; voting outcomes and the scrutineer's report, to be released later, will be the next material event for investors.